The 20-kD human growth hormone reduces body fat by increasing lipolysis and decreasing lipoprotein lipase activity.
OBJECTIVE
The aim of this study was to estimate the lipolytic activity of the human growth hormone variant, 20-kD human growth hormone (20K-hGH).


METHODS
Obese KV-A(y) mice were given daily subcutaneous injections of 20K-hGH (0.25, 0.5, 1.0 mg/kg), 22K-hGH (0.25 mg/kg) or saline as a control for 2 weeks. Body composition (fat, water and protein), lipolysis and lipoprotein lipase (LPL) activity were measured 24 h after the final injection.


RESULTS
Both growth hormone isoforms significantly reduced relative fat pad and whole body lipids. In addition, 20K-hGH produced an inhibition of LPL activity in adipose tissue and stimulated lipolysis in adipocytes.


CONCLUSIONS
These data strongly suggest that inhibition of LPL activity in adipose tissue and stimulation of lipolysis in adipocytes by 20K-hGH treatment reduce adipose tissue mass, resulting in body fat reduction.
D017667:Adipocytes / Q000187:drug effects / Q000378:metabolism; D000273:Adipose Tissue / Q000033:anatomy & histology / Q000201:enzymology / Q000378:metabolism*; D000818:Animals; D001823:Body Composition / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004822:Epididymis; D005260:Female; D019382:Human Growth Hormone / Q000494:pharmacology*; D008066:Lipolysis / Q000187:drug effects*; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D051379:Mice; D009929:Organ Size / Q000187:drug effects; D015430:Weight Gain / Q000187:drug effects
D004791:Enzyme Inhibitors; D019382:Human Growth Hormone; D008071:Lipoprotein Lipase